Tripi S - Search Results

1

Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis.

Stroffolini T, Almasio PL, Di Stefano R, Andreone P, Di Gaetano G, Fattovich G, Gaeta GB, Morisco F, Smedile A, Tripi S, Zignego AL, Ferraro D, Mele A, Craxi A. Stroffolini T, et al. Among authors: tripi s. Dig Liver Dis. 2002 Sep;34(9):656-9. doi: 10.1016/s1590-8658(02)80209-2. Dig Liver Dis. 2002. PMID: 12405253

2

Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon.

Montalto G, Tripi S, Cartabellotta A, Fulco M, Soresi M, Di Gaetano G, Carroccio A, Levrero M. Montalto G, et al. Among authors: tripi s. Am J Gastroenterol. 1998 Jun;93(6):950-3. doi: 10.1111/j.1572-0241.1998.00285.x. Am J Gastroenterol. 1998. PMID: 9647026

3

[Factors predicting the response to alpha-interferon therapy in patients with chronic hepatitis C].

Soresi M, Tripi S, Cartabellotta A, di Gaetano G, Carroccio A, Amato S, Migneco G, Montalto G. Soresi M, et al. Among authors: tripi s. Recenti Prog Med. 1996 Apr;87(4):154-7. Recenti Prog Med. 1996. PMID: 8643875 Clinical Trial. Italian.

4

Interferon-alpha alone versus interferon-alpha plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-alpha treatment.

Tripi S, Di Gaetano G, Soresi M, Cartabellotta F, Vassallo R, Carroccio A, Anastasi G, Montalto G. Tripi S, et al. BioDrugs. 2000 Apr;13(4):299-304. doi: 10.2165/00063030-200013040-00008. BioDrugs. 2000. PMID: 18034536

5

Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis.

Caruso C, Candore G, Cigna D, Tripi S, Di Gaetano G, Migneco G, Montalto G, Ruggieri I, Notarbartolo A. Caruso C, et al. Among authors: tripi s. Mediators Inflamm. 1994;3(3):185-7. doi: 10.1155/S0962935194000256. Mediators Inflamm. 1994. PMID: 18472940 Free PMC article.

6

Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons.

Tripi S, Soresi M, Di Gaetano G, Carroccio A, Giannitrapani L, Vuturo O, Di Giovanni G, Montalto G. Tripi S, et al. BioDrugs. 2003;17(3):201-5. doi: 10.2165/00063030-200317030-00006. BioDrugs. 2003. PMID: 12749756 Clinical Trial.

7

Randomised Trial of Two Different Daily Doses of Interferon-α versus Classical Therapy in Treatment-Naïve Patients with Chronic Hepatitis C.

Montalto G, Tripi S, Vuturo O, Di Gaetano G, Soresi M, Spadaro A, Aiello A, Russello M, Benigno R, Siciliano R. Montalto G, et al. Among authors: tripi s. Clin Drug Investig. 2002 Sep;22(9):623-631. doi: 10.2165/00044011-200222090-00007. Clin Drug Investig. 2002. PMID: 29492856

8

Percutaneous liver biopsy: a safe outpatient procedure?

Montalto G, Soresi M, Carroccio A, Bascone F, Tripi S, Aragona F, Di Gaetano G, Notarbartolo A. Montalto G, et al. Among authors: tripi s. Digestion. 2001;63(1):55-60. doi: 10.1159/000051873. Digestion. 2001. PMID: 11173901

9

Prevalence of hepatitis B virus infection in chronic users of hepatotoxic drugs and alcoholic cirrhotic patients.

Migneco G, Mascarella A, Tripi S, La Cascia C, Cusimano R, Vigneri S, Attianese R, Scialabba A. Migneco G, et al. Among authors: tripi s. Boll Ist Sieroter Milan. 1987;66(3):181-4. Boll Ist Sieroter Milan. 1987. PMID: 3435649

10

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.

Soresi M, Tripi S, Franco V, Giannitrapani L, Alessandri A, Rappa F, Vuturo O, Montalto G. Soresi M, et al. Among authors: tripi s. Liver Int. 2006 Nov;26(9):1119-25. doi: 10.1111/j.1478-3231.2006.01347.x. Liver Int. 2006. PMID: 17032413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters